By: Sumit Jha
The government laboratory's test certificate classified the seized sample as “Not of Standard Quality and Misbranded Drug” under the Drugs and Cosmetics Act, 1940 and the Rules made under it.
Sumit Jha is an Assistant Managing Editor at The Economic Times. He focuses on health and wellness, covering a range of topics including diet and nutrition, mental health care, oncology, and public health, while also exploring the intersection of culture and society within healthcare. Sumit has been featured in notable publications such as Mercom India, TheWire.in, and South First.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Sumit Jha's coverage is primarily focused on local government announcements and scientific topics related to health, medicine, and the pandemic. He often cites data in his articles, indicating a preference for fact-based reporting.
Given Sumit's strong focus on health-related issues such as Covid-19, medical studies, and local healthcare events in Southern India, he is likely to be interested in pitches that provide unique insights into these areas from experts based in or familiar with the region. Topics such as public health initiatives or new scientific research findings related to healthcare would also align well with his coverage.
Those who can offer data-driven analysis or commentary on government policies pertaining to healthcare within Southern India may find their pitches resonate strongly with Sumit.
This information evolves through artificial intelligence and human feedback. Improve this profile .